Cargando…

High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients

BACKGROUND: Despite recent advances in cancer therapeutics in general, the survival of patients with head and neck squamous cell carcinomas (HNSCCs) has not improved substantially over the past few decades. HNSCC cells often exhibit invasive and metastatic phenotypes, and expression of epidermal gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Hiroki, Hatanaka, Kanako C, Hatanaka, Yutaka, Hatakeyama, Hiromitsu, Hashimoto, Ari, Matsuno, Yoshihiro, Fukuda, Satoshi, Sabe, Hisataka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995662/ https://www.ncbi.nlm.nih.gov/pubmed/24621372 http://dx.doi.org/10.1186/1478-811X-12-17

Ejemplares similares

High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue
por: Otsuka, Yutaro, et al.
Publicado: (2016)

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy
por: Kinoshita, Rumiko, et al.
Publicado: (2013)

High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer
por: Tsutaho, Akio, et al.
Publicado: (2020)

Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
por: Onodera, Yasuhito, et al.
Publicado: (2012)

Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model
por: Otsuka, Yutaro, et al.
Publicado: (2018)

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)
por: Sabe, Hisataka, et al.
Publicado: (2009)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells
por: Handa, Haruka, et al.
Publicado: (2018)

AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions
por: Tien, Dat Nguyen, et al.
Publicado: (2014)

GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis
por: Hashimoto, Ari, et al.
Publicado: (2011)

Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021)

ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
por: Hashimoto, Shigeru, et al.
Publicado: (2019)

Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: a pilot study
por: Mizushima, Takeshi, et al.
Publicado: (2016)

PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer
por: Ishida, Naoko, et al.
Publicado: (2018)

Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
por: Fujiwara, Kento, et al.
Publicado: (2020)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
por: Suzuki, Takayoshi, et al.
Publicado: (2021)

p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
por: Yamamoto, Mitsugu, et al.
Publicado: (2014)

Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma
por: Ueno, Takashi, et al.
Publicado: (2018)

A case of sarcoidosis with eosinophilia in peripheral blood and bronchoalveolar lavage fluid
por: Takahashi, Ayumu, et al.
Publicado: (2013)

Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
por: Naka, Tomoaki, et al.
Publicado: (2016)

Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature
por: Hatanaka, Kanako C., et al.
Publicado: (2019)

The Potential Diagnostic Role of the Number of Ultrasonographic Characteristics for Patients with Thyroid Nodules Evaluated as Bethesda I–V
por: Sakashita, Tomohiro, et al.
Publicado: (2014)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells
por: Handa, Haruka, et al.
Publicado: (2017)

Fatty acid‐binding protein 5 function in hepatocellular carcinoma through induction of epithelial–mesenchymal transition
por: Ohata, Takanori, et al.
Publicado: (2017)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
por: Sato, Daisuke, et al.
Publicado: (2016)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

Two cases of hard metal lung disease showing gradual improvement in pulmonary function after avoiding dust exposure
por: Terui, Hiroya, et al.
Publicado: (2015)

β1-integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer
por: Nam, Jin-Min, et al.
Publicado: (2013)

Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer
por: Hashimoto, Ari, et al.
Publicado: (2021)

Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor
por: Naka, Tomoaki, et al.
Publicado: (2022)

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer
por: Oguro, Seiji, et al.
Publicado: (2015)

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
por: Morimoto, Hirofumi, et al.
Publicado: (2021)

Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
por: Mizukami, Tatsuzo, et al.
Publicado: (2014)

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
por: Hagio, Kanako, et al.
Publicado: (2023)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
por: Iwata, Hiromitsu, et al.
Publicado: (2019)

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
por: Mitamura, Takashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqkatqdst2da7gumg5fb4qod98